there is some evidence that interleukin 10 may inhibit it in an animal model it is classified as type ii lupus nephritis by the world health organization who common shorthand for the condition is mespgn mesangial cells in the renal glomerulus use endocytosis to take up and degrade circulating immunoglobulin this normal process stimulates mesangial cell proliferation and matrix deposition therefore during times of elevated circulating immunoglobulin i e lupus and iga nephropathy one would expect to see an increased number of mesangial cells and matrix in the glomerulus this is characteristic of nephrotic syndromes the clinical presentation of mespgn is varied although persistent or recurring microscopic or macroscopic hematuria with mild proteinuria is most common studies are performed in most patients to exclude known causes mespgn can also be a finding in resolving postinfectious isolated deposits with scanty subendothelial or subepithelial hump like deposits on electron microscopy may be seen in this situation indicating a likelihood of mespgn of the eleven known cases of nephrotic syndrome three early cases went untreated subsequently four were treated with steroids and four treated with steroids and cytotoxic drugs one in each group achieved remission while the remaining patients continued to have steroid